The National Institutes of Health has canceled funding for at least 383 clinical trials in the last year, affecting some ...
A study found that Trump administration NIH grant cuts led to termination of 118 trials studying cancer, 97 studying ...
CenExel, a leading network of clinical research sites, is hosting a two-day Good Clinical Practice (GCP) training initiative ...
A new study has shown that a clinical tool developed by the University of Liverpool and The Walton Center can accurately ...
11h
Inhibikase Therapeutics Advancing IKT-001 to Global Phase 3 Study in Pulmonary Arterial Hypertension
Phase 3 Study initiating in First Quarter of 2026 Single Pivotal Study Accelerates Potential FDA Approval Timeline by ...
Updated results based on molecular classification and blinded independent central review demonstrate clinically meaningful ...
Clinical stage biotech Tryptamine Therapeutics has achieved a major milestone in the development of its novel IV-infused ...
A novel comprehensive textbook on medical device clinical research, authored by Dr Ashish Indani, has been released, offering end-to-end guidance for professionals navigating the rapidly ...
Partial response observed in a MEK-rechallenge 3rd-line melanoma patient with BRAF V600E mutation who remains on trial for ...
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that Caidya, a ...
Paradromics Inc., a neurotechnology company developing the highest data-rate brain-computer interface (BCI) platform, today announced the US FDA has granted Investigational Device Exemption (IDE) ...
Reports of halted research and clinical trials contradict Health Secretary Robert F. Kennedy Jr.’s statement that the Trump administration hasn’t cut science and research. One recent research letter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback